2021
DOI: 10.1016/j.ejim.2021.05.036
|View full text |Cite
|
Sign up to set email alerts
|

SHARPEN score accurately predicts in-hospital mortality in infective endocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
1
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 7 publications
0
8
1
1
Order By: Relevance
“…Including both surgical and non-surgical cohort, the score had a good performance (AUC: 0.76; 95% CI: 0.67-0.85; p < 0.001). 78 Another study by Chee et al, through an 11-year study, also independently correlated with mortality. The score was stratified into low risk (2-6), moderate risk (7-10), and high risk (11)(12)(13)(14)(15)(16)(17)(18)(19)(20) groups, with a good predictive performance (AUC: 0.86; 95% CI: 0.80-0.91; p < 0.001).…”
Section: Sharpenmentioning
confidence: 90%
See 1 more Smart Citation
“…Including both surgical and non-surgical cohort, the score had a good performance (AUC: 0.76; 95% CI: 0.67-0.85; p < 0.001). 78 Another study by Chee et al, through an 11-year study, also independently correlated with mortality. The score was stratified into low risk (2-6), moderate risk (7-10), and high risk (11)(12)(13)(14)(15)(16)(17)(18)(19)(20) groups, with a good predictive performance (AUC: 0.86; 95% CI: 0.80-0.91; p < 0.001).…”
Section: Sharpenmentioning
confidence: 90%
“…The SHARPEN score includes systolic blood pressure <90 mm Hg at presentation, heart failure, age (with varying score according to the age group: <50, 50–65, and >65 years), renal function (>2.26 mg/dL), pneumonia (⩾48 h after admission), elevated peak CRP (>200 mg/L during hospitalization), and non-intravenous drug abuser. 78 This score was recently validated, in a retrospective study that included 179 hospitalized patients for IE, with variable presentation and complications. This study found a sensitivity of 70.0% and specificity of 71.2%, positive predictive value of 41.1%, and negative predictive value of 89.2% with a score of 10 as a cut-off.…”
Section: Sharpenmentioning
confidence: 99%
“…SHARPEN é um escore de risco para EI desenvolvido por Chee et al 11 para predizer mortalidade hospitalar em pacientes operados e não operados. 25 Nosso estudo tem como objetivo avaliar o valor prognóstico do escore SHARPEN durante a internação por EI tanto em pacientes operados como não operados, além de comparar seu desempenho com o Índice de Comorbidade de Charlson (ICC). 26 …”
Section: Introductionunclassified
“…SHARPEN is a risk score for IE developed by Chee et al 11 to predict in-hospital mortality in operated and non-operated patients. 25 Our study aims to prognostic value of SHARPEN score during hospitalization and after discharge in both operated and non-operated patients admitted for IE and to compare its performance with that of the Charlson comorbidity index (CCI). 26 …”
Section: Introductionmentioning
confidence: 99%
“…IE still represents a significant public health problem in terms of morbidity and mortality. Only a few studies examined predictive factors for mortality in IE [ 11 , 12 , 13 , 14 , 15 , 16 ]. The aim of this study was to assess which risk factors were associated with poorer outcomes in IE patients admitted to an infectious disease unit in Central Italy.…”
Section: Introductionmentioning
confidence: 99%